The DOT's proposed rule would add fentanyl and norfentanyl to mandatory drug testing panels for transportation workers under ...
The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The ...
After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal ...
The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.
Chemists at Université de Montréal have developed "signaling cascades" made with DNA molecules to report and quantify the ...
More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings ...
Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 ...
Consumers have testing options beyond the once-a-decade colonoscopy. But some doctors question Cologuard's testing program.
Scientists suggest approach could be leveraged for a wide range of chemical applications, with complex, workflows streamlined into a rapid, single-step reaction.
The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback